A Double-Blind Placebo-Controlled Study of Lamotrigine Monotherapy in Outpatients With Bipolar I Depression
The DOI matches its Crossref record.
Abstract
BACKGROUND: More treatment options for bipolar depression are needed. Currently available antidepressants may increase the risk of mania and rapid cycling, and mood stabilizers appear to be less effective in treating depression than mania. Preliminary data suggest that lamotrigine, an established antiepileptic drug, may be effective for both the depression and mania associated with bipolar disorder. This is the first controlled multicenter study evaluating lamotrigine monotherapy in the treatment of bipolar I depression. METHODS: Outpatients with bipolar I disorder experiencing a major depressive episode (DSM-IV, N = 195) received lamotrigine (50 or 200 mg/day) or placebo as monotherapy for 7 weeks. Psychiatric evaluations, including the Hamilton Rating Scale for Depression (HAM-D), the Montgomery-Asberg Depression Rating Scale (MADRS), Mania Rating Scale, and the Clinical Global Impressions scale for Severity (CGI-S) and Improvement (CGI-I) were completed at each weekly visit. RESULTS: Lamotrigine 200 mg/day demonstrated significant antidepressant efficacy on the 17-item HAM-D, HAM-D Item 1, MADRS, CGI-S, and CGI-I compared with placebo. Improvements were seen as early as week 3. Lamotrigine 50 mg/day also demonstrated efficacy compared with placebo on several measures. The proportions of patients exhibiting a response on CGI-I were 51%, 41%, and 26% for lamotrigine 200 mg/day, lamotrigine 50 mg/day, and placebo groups, respectively. Adverse events and other safety results were similar across treatment groups, except for a higher rate of headache in the lamotrigine groups. CONCLUSION: Lamotrigine monotherapy is an effective and well-tolerated treatment for bipolar depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“while clinical experience and the results of many studies suggest that response to mood stabilizers and antipsychotics is similar in BDII and BDI, there are enough exceptions to suggest this should not be taken for granted.248, 405, 431”
Citations
Cites
Still being checked.
Cited by
Items 201–300 of 1,000
Schindler, F., & Anghelescu, I. G. (2007) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328014823d · Cited by 65
Pharmacotherapy of bipolar mixed states
Krüger, S., Trevor Young, L., & Bräunig, P. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00197.x · Cited by 68
Keck, P. E., McElroy, S. L., & Arnold, L. M. (2001) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70334-5 · Cited by 86
Möller, H. ‐., Grunze, H., & Broich, K. (2005) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-005-0591-9 · Cited by 73
The treatment of bipolar depression
Sachs, G. S., Koslow, C. L., & Ghaemi, S. N. (2000) · Bipolar Disorders · doi:10.1034/j.1399-5618.2000.20306.x · Cited by 58
Self-citationBipolar Depression: Management Options
Malhi, G. S., Mitchell, P. B., & Salim, S. (2003) · CNS Drugs · doi:10.2165/00023210-200317010-00002 · Cited by 70
Calabrese, J. R., Goldberg, J. F., Ketter, T. A., Suppes, T. M., Frye, M. A., White, R., DeVeaugh‐Geiss, A., & Thompson, T. R. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.034 · Cited by 64
Self-citationPlacebo effect in randomized, controlled studies of acute bipolar mania and depression
Keck, P. E., Welge, J. A., McElroy, S. L., Arnold, L. M., & Strakowski, S. M. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00311-x · Cited by 88
Gabapentin augmentation therapy in bipolar depression
Wang, P. W., Santosa, C., Schumacher, M., Winsberg, M. E., Strong, C., & Ketter, T. A. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.01211.x · Cited by 63
Anticonvulsants in bipolar disorders: current research and practice and future directions
Bowden, C. L. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00708.x · Cited by 72
Self-citationPlatelet Glutamate Receptor Supersensitivity in Major Depressive Disorder
Berk, M., Plein, H., & Ferreira, D. (2001) · Clinical Neuropharmacology · doi:10.1097/00002826-200105000-00002 · Cited by 64
Seo, H.-J., Chiesa, A., Lee, S.-J., Patkar, A. A., Han, C., Masand, P. S., Serretti, A., & Pae, C.-U. (2011) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3182055c07 · Cited by 64
Kingsberg, S. A., Simon, J. A., & Goldstein, I. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.00961.x · Cited by 66
Kemp, D. E., Ganocy, S. J., Brecher, M., Carlson, B. X., Edwards, S., Eudicone, J. M., Evoniuk, G., Jansen, W., Leon, A. C., Minkwitz, M., et al. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.10.026 · Cited by 62
Self-citationAdjunctive Aripiprazole in Treatment-Resistant Bipolar Depression
Ketter, T. A., Wang, P. W., Chandler, R. A., Culver, J. L., & Alarcon, A. M. (2006) · Annals of Clinical Psychiatry · doi:10.1080/10401230600801176 · Cited by 63
van der Loos, M. L., Mulder, P., Hartong, E. G., Blom, M. B., Vergouwen, A. C., van Noorden, M. S., Timmermans, M. A., Vieta, E., Nolen, W. A., & for the LamLit Study Group* (2011) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00887.x · Cited by 61
Maj, M., Pirozzi, R., Magliano, L., & Bartoli, L. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.10.1711 · Cited by 61
The Diverse Roles of Anticonvulsants in Bipolar Disorders
Ketter, T. A., Wang, P. W., Becker, O. V., Nowakowska, C., & Yang, Y.-S. (2003) · Annals of Clinical Psychiatry · doi:10.1023/a:1024636309185 · Cited by 62
Lamotrigine in the treatment of bipolar depression
Bowden, C. L., Mitchell, P. B., & Suppes, T. M. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(99)00024-3 · Cited by 61
Self-citationPharmacotherapy of depression and mixed states in bipolar disorder
Montgomery, S., Schatzberg, A. F., Guelfi, J., Kasper, S. F., Nemeroff, C. B., Swann, A. C., & Zajecka, J. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00178-6 · Cited by 70
Mood-Stabilizers Target the Brain Arachidonic Acid Cascade
Rao, J. S., & Rapoport, S. I. (2009) · Current Molecular Pharmacology · doi:10.2174/1874-470210902020207 · Cited by 58
Pharmacotherapy for the Treatment of Acute Bipolar II Depression: Current Evidence
Swartz, H. A., & Thase, M. E. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09r05192gre · Cited by 60
Pharmacological management of the psychiatric aspects of traumatic brain injury
Lee, H. B., Lyketsos, C. G., & Rao, V. (2003) · International Review of Psychiatry · doi:10.1080/09540260310001606746 · Cited by 63
Premkumar, T. S., & Pick, J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005962.pub2 · Cited by 55
Anticonvulsants in bipolar disorder
Grunze, H. (2010) · Journal of Mental Health · doi:10.3109/09638230903469186 · Cited by 66
Brain-derived neurotrophic factor signalling mediates antidepressant effects of lamotrigine
Li, N., He, X., Zhang, Y., Qi, X., Li, H., Zhu, X., & He, S. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001082 · Cited by 57
Latest maintenance data on lamotrigine in bipolar disorder
Calabrese, J. R., Vieta, E., & Shelton, M. D. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(03)00079-8 · Cited by 63
Self-citationThe effectiveness of anticonvulsants in psychiatric disorders
Grunze, H. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.1/hcrgrunze · Cited by 67
New anti-epileptic drugs for the 21st century
McCabe, P. H. (2000) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.1.4.633 · Cited by 66
Shi, L., Namjoshi, M. A., Swindle, R. W., Yu, X., Risser, R. C., Baker, R. W., & Tohen, M. F. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)90013-6 · Cited by 64
Interferon-induced depression: strategies in treatment.
Asnis, G., & Garza, R. I. D. L. (2005) · Progress in Neuro-psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.03.006 · Cited by 59
An ever-increasing pharmacopoeia for the management of patients with bipolar disorder.
Nemeroff, C. B. (2000) · PubMed · Cited by 64
Consoni, F. T., Vital, M. A. B. F., & Andreatini, R. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.01.003 · Cited by 59
A systematic review on the role of anticonvulsants in the treatment of acute bipolar depression
Reinares, M., Rosa, A. R., Franco, C., Goikolea, J. M., Fountoulakis, K., Siamouli, M., Gonda, X., Frangou, S., & Vieta, E. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000491 · Cited by 56
Van Lieshout, R. J., & MacQueen, G. M. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.057612 · Cited by 57
Lamotrigine for bipolar disorder and comorbid cocaine dependence: A replication and extension study
Brown, E. S., Perantie, D. C., Dhanani, N., Beard, L., Orsulak, P. J., & Rush, A. J. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.02.001 · Cited by 57
Cognitive Functioning in Bipolar Patients Receiving Lamotrigine
Daban, C., Martínez‐Arán, A., Torrent, C., Sánchez‐Moreno, J., Goikolea, J. M., Benabarre, A., Comes, M., Colom, F., & Vieta, E. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000204332.64390.f3 · Cited by 56
Tamayo, J. M., Zarate, C. A., Vieta, E., Vázquez, G. H., & Tohen, M. F. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709991246 · Cited by 57
Managing Bipolar Disorder in the Elderly: Defining the Role of the Newer Agents
Sajatovic, M., Madhusoodanan, S., & Coconcea, N. (2005) · Drugs & Aging · doi:10.2165/00002512-200522010-00003 · Cited by 64
Yatham, L. N., Calabrese, J. R., & Kusumakar, V. (2003) · Bipolar Disorders · doi:10.1034/j.1399-5618.2003.00019.x · Cited by 59
Self-citationHCN Channel Targets for Novel Antidepressant Treatment
Ku, S. M., & Han, M.-H. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0538-7 · Cited by 54
Malhi, G. S., Adams, D., Cahill, C. M., Dodd, S., & Berk, M. (2009) · Drugs · doi:10.2165/11318850-000000000-00000 · Cited by 64
Medicating mood with maintenance in mind: bipolar depression pharmacotherapy
Malhi, G. S., Adams, D., & Berk, M. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00711.x · Cited by 59
Carbamazepine in the treatment of cocaine dependence: Subtyping by affective disorder.
Brady, K. T., Sonne, S. C., Malcolm, R. J., Randall, C. L., Simpson, K., Dansky, B. S., Roberts, J. S., & Brondino, M. (2002) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.10.3.276 · Cited by 55
Weisler, R. H., Calabrese, J. R., Bowden, C. L., Ascher, J. A., DeVeaugh-Geiss, J., & Evoniuk, G. E. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.09.012 · Cited by 54
Self-citationLamotrigine and the treatment of mania in bipolar disorder
Berk, M. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(99)00025-5 · Cited by 54
The role of atypical antipsychotics in bipolar depression and anxiety disorders
McIntyre, R., & Katzman, M. (2003) · Bipolar Disorders · doi:10.1111/j.1399-2406.2003.00061.x · Cited by 54
The Expanding Pharmacopoeia for Bipolar Disorder
Mitchell, P. B., & Malhi, G. S. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103933 · Cited by 55
An update of evidence-based treatment of bipolar depression: where do we stand?
Fountoulakis, K. Ν. (2009) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328333e132 · Cited by 57
Spotlight on Lamotrigine in Bipolar Disorder1
Goldsmith, D. R., Wagstaff, A. J., Ibbotson, T., & Perry, C. M. (2004) · CNS Drugs · doi:10.2165/00023210-200418010-00007 · Cited by 53
Comparative Efficacy and Tolerability of Drug Treatments for Bipolar Disorder
Strakowski, S. M., Bello, M. P. D., & Adler, C. M. (2001) · CNS Drugs · doi:10.2165/00023210-200115090-00004 · Cited by 54
Region-specific glutamate changes in patients with unipolar depression
Grimm, S., Luborzewski, A., Schubert, F., Merkl, A., Kronenberg, G., Colla, M., Heuser, I., & Bajbouj, M. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.04.018 · Cited by 52
“Correspondingly, human studies demonstrated antidepressant effects of glutamate release inhibitors such as lamotrigine and riluzole as well as the NMDA receptor antagonist ketamine (Calabrese et al., 1999; Zarate et al., 2004, 2006).”
BackgroundReceptor targets for antidepressant therapy in bipolar disorder: An overview
Fountoulakis, K. Ν., Kelsoe, J. R., & Akiskal, H. S. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.04.043 · Cited by 54
Prescriber's Guide: Stahl's Essential Psychopharmacology
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275 · Cited by 89
Santos, M. A., Rocha, F. L., & Hara, C. (2008) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.v10n0302 · Cited by 51
Unmet Clinical Needs in Bipolar Disorder
Sachs, G. S. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000084038.22282.47 · Cited by 52
Self-citationNolen, W. A., Kupka, R. W., Hellemann, G., Frye, M. A., Altshuler, L. L., Leverich, G. S., Suppes, T., Keck, P. E., McElroy, S., Grunze, H., et al. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.00993.x · Cited by 53
Bipolar disorder in neurologic illness
Schneck, C. D. (2002) · Current Treatment Options in Neurology · doi:10.1007/s11940-002-0015-3 · Cited by 53
Baghai, T. C., Blier, P., Baldwin, D. S., Bauer, M., Goodwin, G. M., Fountoulakis, K. Ν., Kasper, S. F., Leonard, B. E., Malt, U. F., Stein, D. J., et al. (2011) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-011-0259-6 · Cited by 57
Leng, Y., Fessler, E. B., & Chuang, D.-M. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000429 · Cited by 51
A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder
Yatham, L. N. (2011) · Journal of Affective Disorders · doi:10.1016/s0165-0327(11)70005-2 · Cited by 51
Kasper, S. F., Calabrese, J. R., Johnson, G., Tajima, O., Vieta, E., Viguera, A. C., Yatham, L. N., & Young, A. H. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n1014 · Cited by 59
Self-citationAcceleration and augmentation strategies for treating bipolar depression
Altshuler, L. L., Frye, M. A., & Gitlin, M. J. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00087-8 · Cited by 53
Reevaluating therapies for bipolar depression.
Grunze, H. (2005) · PubMed · Cited by 53
Glutamate and its role in psychiatric illness
Belsham, B. (2001) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.279 · Cited by 61
Kupka, R. W., Nolen, W. A., Altshuler, L. L., Frye, M. A., Denicoff, K. D., Leverich, G. S., Post, R. M., Keck, P. E., McElroy, S. L., Rush, A. J., et al. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.41.s177 · Cited by 49
Treatment options for acute depression in bipolar disorder
Bauer, M., Ritter, P., Grunze, H., & Pfennig, A. (2012) · Bipolar Disorders · doi:10.1111/j.1399-5618.2012.00991.x · Cited by 49
Besag, F., Vasey, M. J., Sharma, A., & Lam, I. C. H. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253211045870 · Cited by 62
Lamotrigine suppresses neurophysiological responses to somatosensory stimulation in the rodent
Kida, I., Smith, A. J., Blumenfeld, H., Behar, K. L., & Hyder, F. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.07.015 · Cited by 52
Emerging trends in the treatment of rapid cycling bipolar disorder: a selected review
Post, R. M., Frye, M. A., Denicoff, K. D., Leverich, G. S., Dunn, R. T., Osuch, E. A., Speer, A. M., Obrocea, G., & Jajodia, K. (2000) · Bipolar Disorders · doi:10.1034/j.1399-5618.2000.020403.x · Cited by 49
Lamotrigine augmentation in unipolar depression
Rocha, F. L., & Hara, C. (2003) · International Clinical Psychopharmacology · doi:10.1097/00004850-200303000-00006 · Cited by 49
Treatment of Bipolar Depression, a Review of the Literature and a Suggestion for an Algorithm
Nolen, W. A., & Bloemkolk, D. (2000) · Neuropsychobiology · doi:10.1159/000054845 · Cited by 49
Pharmacological Treatment of Bipolar Depression: What are the Current and Emerging Options?
Yalın, N., & Young, A. H. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s245166 · Cited by 54
Lamotrigine in epilepsy, pregnancy and psychiatry – a drug for all seasons?
Vajda, F. J. E., Dodd, S., & Horgan, D. (2012) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2012.05.024 · Cited by 52
Glutamate modulators as novel interventions for mood disorders
Mathew, S. J., Keegan, K., & Smith, L. (2005) · Revista Brasileira de Psiquiatria · doi:10.1590/s1516-44462005000300016 · Cited by 45
Risk of a lamotrigine-related skin rash: Current meta-analysis and postmarketing cohort analysis
Wang, X.-Q., Xiong, J., Xu, W., Yu, S., Huang, X., Zhang, J., Tian, C.-L., Huang, D., Jia, W.-Q., & Lang, S.-Y. (2014) · Seizure · doi:10.1016/j.seizure.2014.12.001 · Cited by 50
A review of acute treatments for bipolar depression
Silverstone, P. H., & Silverstone, T. (2004) · International Clinical Psychopharmacology · doi:10.1097/00004850-200405000-00001 · Cited by 55
Preventive Treatment of Migraine: Effect on Weight
Young, W., & Rozen, T. (2004) · Cephalalgia · doi:10.1111/j.1468-2982.2004.00819.x · Cited by 47
Advances in the pharmacologic treatment of bipolar depression
Keck, P. E., Nelson, E. B., & McElroy, S. L. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01741-9 · Cited by 49
Brown, E. S., Sunderajan, P., Hu, L. T., Sowell, S. M., & Carmody, T. J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.90 · Cited by 46
“Lamotrigine appears to be useful for depressive symptoms and relapse prevention in bipolar disorder (Calabrese et al, 1999, 2000, 2002).”
BackgroundPharmacological interventions for the treatment of disordered and problem gambling
Dowling, N. A., Merkouris, S., Lubman, D. I., Thomas, S. A., Bowden‐Jones, H., & Cowlishaw, S. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008936.pub2 · Cited by 53
The effects of lamotrigine on the pharmacokinetics of lithium
Chen, C., Veronese, L., & Yin, Y. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00248.x · Cited by 46
Treatment-Resistant Bipolar Disorder
(2012) · Management of Treatment-Resistant Major Psychiatric Disorders · doi:10.1093/med/9780199739981.003.0004 · Cited by 46
Abelaira, H. M., Réus, G. Z., Ribeiro, K. F., Zappellini, G., Ferreira, G. K., Gomes, L. M., Carvalho‐Silva, M., Luciano, T. F., Marques, S. D. O., STRECK, E. L., et al. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.10.007 · Cited by 49
Hamoda, H. M., & Osser, D. N. (2008) · Harvard Review of Psychiatry · doi:10.1080/10673220802277904 · Cited by 47
Bipolar depression: Diagnostic and treatment considerations
Thase, M. E. (2006) · Development and Psychopathology · doi:10.1017/s0954579406060585 · Cited by 55
Reporting outcomes in clinical trials for bipolar disorder: a commentary and suggestions for change
Martínez‐Arán, A., Vieta, E., Chengappa, K. R., Gershon, S., Mullen, J., & Paulsson, B. (2008) · Bipolar Disorders · doi:10.1111/j.1399-5618.2008.00611.x · Cited by 48
Mathew, S. J., Coplan, J. D., Smith, E. L. P., Schoepp, D. D., Rosenblum, L. A., & Gorman, J. M. (2001) · CNS Spectrums · doi:10.1017/s1092852900002091 · Cited by 49
Lamotrigine Use in Geriatric Patients with Bipolar Depression
Robillard, M., & Conn, D. K. (2002) · The Canadian Journal of Psychiatry · doi:10.1177/070674370204700808 · Cited by 45
Refractoriness in Bipolar Disorder: Definitions and Evidence‐Based Treatment
Fountoulakis, K. N. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2011.00259.x · Cited by 44
Lithium treatment — moderate dose use study (LiTMUS) for bipolar disorder: rationale and design
Nierenberg, A. A., Sylvia, L. G., Leon, A. C., Reilly-Harrington, N. A., Ketter, T. A., Calabrese, J. R., Thase, M. E., Bowden, C. L., Friedman, E. S., Ostacher, M. J., et al. (2009) · Clinical Trials · doi:10.1177/1740774509347399 · Cited by 45
Self-citationLamotrigine in the maintenance treatment of bipolar disorder
Hashimoto, Y., Kotake, K., Watanabe, N., Fujiwara, T., & Sakamoto, S. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013575.pub2 · Cited by 46
Combined Use of Lamotrigine and Electroconvulsive Therapy in Bipolar Depression: A Case Series
Penland, H. R., & Ostroff, R. B. (2006) · Journal of Ect · doi:10.1097/00124509-200606000-00013 · Cited by 47
Ostadhadi, S., Ahangari, M. M., Nikoui, V., Norouzi‐Javidan, A., Zolfaghari, S., Jazaeri, F., Chamanara, M., Akbarian, R., & Dehpour, A. R. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.05.035 · Cited by 45
Medication Treatment of Bipolar Disorder 2000: A Summary of the Expert Consensus Guidelines
Kahn, D. A., SACHS, G. S., PRINTZ, D. J., Carpenter, D. P., Docherty, J. P., & ROSS, R. W. (2000) · Journal of Psychiatric Practice · doi:10.1097/00131746-200007000-00004 · Cited by 49
Self-citationPsychopharmacologic Treatment Strategies for Depression, Bipolar Disorder, and Schizophrenia
Glick, I. D., Suppes, T. M., DeBattista, C., Hu, R. J., & Marder, S. R. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-1-200101020-00013 · Cited by 47
CLINICAL PICTURE AND ETIOLOGIC MODELS OF MIXED STATES
Freeman, M. P., & McElroy, S. L. (1999) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70094-0 · Cited by 44
Tratamento do transtorno bipolar: eutimia
Souza, F. G. D. M. E. (2005) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/s0101-60832005000700010 · Cited by 43
The duration of undiagnosed bipolar disorder: Effect on outcomes and treatment response
McCraw, S., Parker, G. B., Graham, R., Synnott, H., & Mitchell, P. B. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.07.025 · Cited by 44
Goldberg, J. F., Bowden, C. L., Calabrese, J. R., Ketter, T. A., Dann, R. S., Frye, M. A., Suppes, T. M., & Post, R. M. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.031 · Cited by 47
Self-citation
Metadata
- Authors
- Calabrese, J. R., Bowden, C. L., Sachs, G. S., Ascher, J. A., Monaghan, E., Rudd, G. D., & The Lamictal 602 Study Group
- Affiliations
- Case Western Reserve University (US)
- GlaxoSmithKline (United Kingdom) (GB)
- ORCID
- Calabrese, Joseph R.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 1999-02-15
- Volume
- 60
- Issue
- 2
- Pages
- 79-88
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2058120764
- Cited by
- 1,054
- References
- 0
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 15 · 2023: 8 · 2022: 8 · 2021: 7 · 2020: 162 · 2019: 10 · 2018: 13 · 2017: 13 · 2016: 13 · 2015: 18 · 2014: 23 · 2013: 24 · 2012: 34
- FWCI
- 47.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Keywords
- lamotrigine, bipolar I depression, bipolar disorder, antidepressant monotherapy, antiepileptic drugs, major depressive episode, treatment response, adverse events, headache, drug tolerability
- MeSH terms
- Lamotrigine, Adult, Aged, Ambulatory Care, Anticonvulsants, Bipolar Disorder, Depressive Disorder, Dose-Response Relationship, Drug, Double-Blind Method, Drug Administration Schedule, Female, Humans, Male, Middle Aged, Patient Compliance, Placebos, Psychiatric Status Rating Scales, Severity of Illness Index, Triazines, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.